Daniel Krell
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Royal Free London NHS Foundation Trust(GB)The Wellington Hospital(GB)
Publications by Year
Research Areas
Neuroendocrine Tumor Research Advances, Glioma Diagnosis and Treatment, Lung Cancer Research Studies, Neuroblastoma Research and Treatments, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Expression of Idh1R132H in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis(2016)153 cited
- → microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis(2015)102 cited
- → Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH Mutations in Glioblastoma(2011)91 cited
- → IDH Mutations in Tumorigenesis and Their Potential Role As Novel Therapeutic Targets(2013)61 cited
- → Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma(2016)56 cited
- → Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours(2019)35 cited